Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=GMD1923 ...

The surge in gluten-free dietary preferences beyond the celiac population and the adoption of innovative non-invasive ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is ...

This Product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older.

Robert F. Kennedy Jr. and the so-called Department of Government Efficiency terminated thousands of experienced public health ...

Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 ...

The study highlights a prevalent choline deficiency and associated liver injury in patients dependent on parenteral support ... data updates on its key products, including the 12-month data ...

IV choline is recommended for patients receiving PS by ASPEN in its Recommendations for Changes in Commercially Available Parenteral Multivitamin and Multi-Trace Element Products, as well as by ...

New Delhi: In line with the wholesale price index (WPI) at 1.74028% for the year 2024 over 2023, through a recent ...

Ironwood Pharmaceuticals, Inc.’s IRWD share price has dipped by 15.22%, which has investors questioning if this is right time ...

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant ...

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ... CorMedix is commencing clinical studies in adult Total ...